Healthcare providers seeking information about appropriate coronavirus disease 2019 (COVID-19) treatment may now consult treatment guidelines developed by a panel of U.S. physicians, statisticians, and other experts. These guidelines are based on published and preliminary data and the clinical expertise of the panelists, many of whom are frontline clinicians caring for patients during the rapidly evolving pandemic. The guidelines will be updated often as new data are published in peer-reviewed scientific literature and as other authoritative information emerges.
The CDC has also published Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)external link for clinicians caring for patients with confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). CDC will update this interim guidance as more information becomes available.
This guidance covers clinical presentation, testing, diagnosis, and clinical management and treatment, among other topics.
In addition, there are a number of clinical trials underway in an effort to inform and optimize the clinical care of patients. By leveraging current NHLBI-supported clinical trial networks—such as the Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Networkexternal link and Strategies to Innovate Emergency Care Clinical Trials Network (SIREN)external link, we have been able to quickly launch COVID-19 clinical trials: